Label: CURODONT REPAIR FLUORIDE PLUS- sodium fluoride sponge
- NDC Code(s): 72247-109-12
- Packager: CREDENTIS AG
- Category: HUMAN OTC DRUG LABEL
Drug Label Information
Updated December 1, 2024
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- ACTIVE INGREDIENTS
- PURPOSE
- USES
- WARNINGS
- KEEP OUT OF REACH OF CHILDREN
-
DIRECTIONS
Usual dosage is one treatment per tooth. After prophylaxis treatment, remove the pellicle of the concerned tooth by using 2% sodium hypochlorite for 10 seconds. Rinse the tooth surface with water. Remove inorganic deposits by pushing together the two cylinders and apply product with sponge on treatment area.
After treatment time of five minutes have patient expectorate residues. For maximum benefits for the prevention of caries, instruct patient not to rinse, eat or drink for 30 minutes.
- OTHER INFORMATION
- INACTIVE INGREDIENTS
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
CURODONT REPAIR FLUORIDE PLUS
sodium fluoride spongeProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:72247-109 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SODIUM FLUORIDE (UNII: 8ZYQ1474W7) (FLUORIDE ION - UNII:Q80VPU408O) FLUORIDE ION 0.02 g in 100 mL Inactive Ingredients Ingredient Name Strength ANHYDROUS CITRIC ACID (UNII: XF417D3PSL) SODIUM HYDROXIDE (UNII: 55X04QC32I) WATER (UNII: 059QF0KO0R) CHLORHEXIDINE GLUCONATE (UNII: MOR84MUD8E) TROMETHAMINE (UNII: 023C2WHX2V) TREHALOSE DIHYDRATE (UNII: 7YIN7J07X4) OLIGOPEPTIDE 104 (UNII: MUM5TLH7X6) HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72247-109-12 10 in 1 BOX 08/27/2023 1 0.1 mL in 1 CYLINDER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M021 08/27/2023 Labeler - CREDENTIS AG (485450345)